Hypothesis: Age-related depletion of gut Clostridium sporogenes and other IPA-producing microbes lowers circulating indole-3-propionic acid (IPA), causing progressive loss of PXR activation in brain microvascular endothelial cells and pericytes. This drives endothelial senescence, pericyte dropout, and blood‑brain barrier (BBB) leakage, which in turn amplifies neuroinflammation and cognitive decline. Restoring intestinal IPA—either by supplementation with IPA or by recolonizing aged mice with an IPA‑producing consortium—will rescue PXR signaling, normalize endothelial senescence markers (p16^INK4a^, SA‑β‑gal), reduce BBB permeability, and improve cognitive performance in a PXR‑dependent manner.

Background

The gut‑derived metabolite IPA activates the pregnane X receptor (PXR) in intestinal epithelial cells to reinforce barrier integrity and in brain endothelial cells to suppress NF‑κB‑mediated inflammation[1][2]. Age‑associated shifts in the microbiota reduce IPA levels, yet no study has linked this deficit to cerebrovascular senescence in aging.

Mechanistic Rationale

We propose that IPA‑PXR signaling sustains a quiescent endothelial phenotype by:

• Upregulating tight‑junction proteins (claudin‑5, ZO‑1) and mucus‑protective enzymes (B3galt5) via direct transcriptional activation.
• Inhibiting the senescence‑associated secretory phenotype (SASP) through blockade of NF‑κB and stabilization of Nrf2‑dependent antioxidant responses.
• Supporting pericyte survival, as pericytes express PXR and rely on its activity to maintain contractile function and TGF‑β signaling. When IPA falls with age, PXR activity wanes, leading to increased endothelial p16^INK4a^ accumulation, SA‑β‑gal positivity, and pericyte detachment. The resulting BBB leak allows systemic inflammatory mediators to enter the parenchyma, exacerbating microglial activation and neuronal damage.

Testable Predictions

1. Aged mice will show reduced fecal and plasma IPA, increased gut permeability (FITC‑dextran assay), and elevated brain endothelial senescence markers compared with young controls.
2. Oral IPA supplementation in aged mice will restore plasma IPA, tighten the gut barrier, decrease brain endothelial p16^INK4a^ and SA‑β‑gal, and improve BBB integrity.
3. Transplanting an IPA‑producing microbial consortium into germ‑free aged mice will replicate the rescue seen with IPA supplementation.
4. Co‑administration of a PXR antagonist (or using Nr1i2^−/− mice) will abolish the protective effects of IPA or microbial restoration on endothelial senescence and BBB leakage.
5. Cognitive rescue (Morris water maze latency) will correlate with improvements in pericyte coverage (PDGFRβ^+^ area) and reductions in pro‑inflammatory cytokines (IL‑1β, TNF‑α) only when PXR signaling is intact.

Experimental Design

• Groups (n=10 per group): Young (3 mo) wild‑type; Aged (20 mo) wild‑type; Aged + IPA (10 mg/kg/day oral gavage); Aged + IPA‑producing microbiota (oral gavage of filtered feces from young donors enriched for C. sporogenes); Aged + IPA + PXR antagonist (GSK‑805); Aged + IPA in Nr1i2^−/− background; Germ‑free aged mice reconstituted with either IPA‑deficient or IPA‑producing consortia.
• Measurements (at baseline, 4 weeks, 8 weeks):
  • Fecal and plasma IPA (LC‑MS/MS).
  • Gut permeability: serum FITC‑dextran after oral gavage.
  • Brain endothelial senescence: immunostaining for p16^INK4a^ and SA‑β‑gal; quantification of % positive CD31^+^ cells.
  • Pericyte coverage: PDGFRβ^+^ length per vessel.
  • BBB leakage: Evans blue extravasation.
  • Neuroinflammation: ELISA for IL‑1β, TNF‑α, IL‑6 in hippocampal homogenates.
  • Behavior: Morris water maze (escape latency, probe trial).
  • PXR activity: qPCR of canonical targets (Cyp3a11, Abcb1a) in isolated brain endothelia.
• Controls: Vehicle‑treated aged mice; microbiota transplant from aged donors; antibiotic‑treated groups to confirm microbiota dependence.

Potential Outcomes and Interpretation

If the hypothesis is correct, IPA supplementation or microbiota reconstitution will normalize gut permeability, elevate brain PXR target expression, reduce endothelial and pericyte senescence markers, restore BBB integrity, lower neuroinflammatory cytokines, and improve spatial memory. These effects will be absent when PXR is pharmacologically blocked or genetically Nr1i2^−/−, confirming a PXR‑dependent mechanism. Conversely, if IPA manipulation fails to affect brain endothelial senescence or BBB leakage despite restoring gut barrier function, the hypothesis would be falsified, suggesting that circulating IPA does not reach sufficient concentrations in the neurovascular unit or that other age‑derived metabolites dominate the gut‑brain signaling axis.